Advisory Council for the Elimination of Tuberculosis Meeting (ACET), 71803 [2015-29260]
Download as PDF
<![CDATA[
71803
Federal Register / Vol. 80, No. 221 / Tuesday, November 17, 2015 / Notices
M. tuberculosis susceptibility testing.
Participation in this program is one way
laboratories can ensure high-quality
laboratory testing, resulting in accurate
and reliable testing results.
By providing an evaluation program
to assess the ability of the laboratories
to test for drug resistant M. tuberculosis
strains, laboratories also have a selfassessment tool to aid in optimizing
their skills in susceptibility testing. The
information obtained from the
laboratories on susceptibility practices
and procedures is used to establish
variables related to good performance,
assessing training needs, and aid with
the development of practice standards.
The data collected over the previous
three-year period enabled CDC to
correlate testing practices with
performance and to use this information
to design training modules targeted to
participants encouraging the adaptation
of advanced testing methods. Extension
of data collection will allow CDC to
evaluate the effectiveness of these
training modules by continually
monitoring laboratory performance.
Participants in this program include
domestic clinical and public health
laboratories. Data collection from
laboratory participants occurs twice per
year. The data collected in this program
will include the susceptibility test
results of primary and secondary drugs,
drug concentrations, and test methods
performed by laboratories on a set of
performance evaluation (PE) samples.
The PE samples are sent to participants
twice a year. Participants also report
demographic data such as laboratory
type and the number of tests performed
annually.
There is no cost to respondents to
participate other than their time.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses per
respondent
Participant Biosafety Compliance Letter of Agreement ...
MPEP Mycobacterium tuberculosis Results Worksheet ..
Online Survey Instrument ................................................
93
93
93
2
2
2
5/60
30/60
15/60
16
93
47
...........................................................................................
93
6
........................
156
Form name
Domestic Laboratory
Total .................
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2015–29272 Filed 11–16–15; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Council for the Elimination of
Tuberculosis Meeting (ACET)
mstockstill on DSK4VPTVN1PROD with NOTICES
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting of the
aforementioned committee:
Times and Dates:
8:30 a.m.–5:00 p.m., EST, December 15, 2015
8:30 a.m.–12:00 p.m., EST, December 16,
2015
Place: Corporate Square, Corporate
Boulevard, Building 8, 1st Floor Conference
Room, Atlanta, Georgia 30329, telephone
(404) 639–8317.
This meeting is also accessible by Webinar:
December 15, 2015
For Participants:
URL: https://www.mymeetings.com/nc/join/
Conference number: PW1126536
Audience passcode: 6816256
Participants can join the event directly at:
VerDate Sep<11>2014
Average
burden per
response
(in hours)
Number of
respondents
Type of respondent
18:14 Nov 16, 2015
Jkt 238001
https://www.mymeetings.com/nc/join.php?i=
PW1126536&p=6816256&t=c
USA Toll-free +1 (888) 947–9021, Participant
code: 6816256
December 16, 2015
For Participants:
URL: https://www.mymeetings.com/nc/join/
Conference number: PW5803596
Audience passcode: 6816256
Participants can join the event directly at:
https://www.mymeetings.com/nc/join.php?i=
PW5803596&p=6816256&t=c
USA Toll-free +1 (888) 947–9021, Participant
code: 6816256
Status: Open to the public, limited only by
the space available. The meeting room
accommodates approximately 100 people.
Purpose: This Council advises and makes
recommendations to the Secretary of Health
and Human Services, the Assistant Secretary
for Health, and the Director, CDC, regarding
the elimination of tuberculosis. Specifically,
the Council makes recommendations
regarding policies, strategies, objectives, and
priorities; addresses the development and
application of new technologies; and reviews
the extent to which progress has been made
toward eliminating tuberculosis.
Matters for Discussion: Agenda items
include the following topics: (1) Overview of
Biomedical Advanced Research and
Development Authority (BARDA); (2)
Tuberculosis in Congregate Settings; (3)
Updates from Workgroups; and (4) other
tuberculosis-related issues.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Margie Scott-Cseh, Centers for Disease
Control and Prevention, 1600 Clifton Road
NE., M/S E–07, Atlanta, Georgia 30333,
telephone (404) 639–8317 Email: zkr7@
cdc.gov.
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
Total burden hours
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register Notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2015–29260 Filed 11–16–15; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Statement of Organization, Functions,
and Delegations of Authority
Part C (Centers for Disease Control
and Prevention) of the Statement of
Organization, Functions, and
Delegations of Authority of the
Department of Health and Human
Services (45 FR 67772–76, dated
October 14, 1980, and corrected at 45 FR
69296, October 20, 1980, as amended
most recently at 80 FR 58479–58485,
dated September 29, 2015) is amended
to reflect the reorganization of the
National Center for Immunization and
Respiratory Diseases, and the Office of
Infectious Diseases, Centers for Disease
Control and Prevention.
E:\FR\FM\17NON1.SGM
17NON1
]]>Agencies
[Federal Register Volume 80, Number 221 (Tuesday, November 17, 2015)]
[Notices]
[Page 71803]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-29260]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Council for the Elimination of Tuberculosis Meeting
(ACET)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC), announces the following meeting of the aforementioned
committee:
Times and Dates:
8:30 a.m.-5:00 p.m., EST, December 15, 2015
8:30 a.m.-12:00 p.m., EST, December 16, 2015
Place: Corporate Square, Corporate Boulevard, Building 8, 1st
Floor Conference Room, Atlanta, Georgia 30329, telephone (404) 639-
8317.
This meeting is also accessible by Webinar:
December 15, 2015
For Participants:
URL: https://www.mymeetings.com/nc/join/
Conference number: PW1126536
Audience passcode: 6816256
Participants can join the event directly at:
https://www.mymeetings.com/nc/join.php?i=PW1126536&p=6816256&t=c
USA Toll-free +1 (888) 947-9021, Participant code: 6816256
December 16, 2015
For Participants:
URL: https://www.mymeetings.com/nc/join/
Conference number: PW5803596
Audience passcode: 6816256
Participants can join the event directly at:
https://www.mymeetings.com/nc/join.php?i=PW5803596&p=6816256&t=c
USA Toll-free +1 (888) 947-9021, Participant code: 6816256
Status: Open to the public, limited only by the space available.
The meeting room accommodates approximately 100 people.
Purpose: This Council advises and makes recommendations to the
Secretary of Health and Human Services, the Assistant Secretary for
Health, and the Director, CDC, regarding the elimination of
tuberculosis. Specifically, the Council makes recommendations
regarding policies, strategies, objectives, and priorities;
addresses the development and application of new technologies; and
reviews the extent to which progress has been made toward
eliminating tuberculosis.
Matters for Discussion: Agenda items include the following
topics: (1) Overview of Biomedical Advanced Research and Development
Authority (BARDA); (2) Tuberculosis in Congregate Settings; (3)
Updates from Workgroups; and (4) other tuberculosis-related issues.
Agenda items are subject to change as priorities dictate.
Contact Person for More Information: Margie Scott-Cseh, Centers
for Disease Control and Prevention, 1600 Clifton Road NE., M/S E-07,
Atlanta, Georgia 30333, telephone (404) 639-8317 Email:
zkr7@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register Notices pertaining
to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention
and the Agency for Toxic Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2015-29260 Filed 11-16-15; 8:45 am]
BILLING CODE 4163-18-P
